Introduction
TCR recognize peptide antigen when presented on the T cells acquire the capacity for MHC-restricted antigen recognition through two types of selection in the thymus (9). surface of cells with molecules encoded by MHC; so-called MHC-restricted antigen recognition (1, 2) . X-ray crystalloPositive selection (10,11) ensures that T cells leaving the thymus express TCR that are capable of MHC-restricted graphic studies have revealed that a TCR interacts not only with a MHC product but also with an antigen-derived peptide antigen recognition. Engagement of TCR on immature thymocytes with self-peptide/MHC molecules, expressed by thymic entrenched in the groove of the MHC molecule (3,4). Peptide is essential for the stable surface expression of class I MHC epithelial cells, rescues cells from programmed cell death (12,13). Thymocytes expressing TCR specific for class II MHC molecules and can be derived from endogenous antigen proteins derived from virus, for example, or from normal differentiate into CD4 ϩ T h cells and those with TCR specific for class I MHC differentiate into cytotoxic T lymphocytes cellular proteins (self-peptides) (5-8). MHC-restricted antigen recognition thus allows T cells to recognize antigens derived (CTL) (14) . Negative selection eliminates those T cells that are potentially autoreactive through clonal deletion (15) and from pathogens that reside within a cell, which may otherwise evade the immune system. Since peptide is an integral is thought to involve engagement of TCRs on immature thymocytes with self-peptide/MHC molecules expressed on structural component of MHC, self-peptide is constitutively presented on the surface of normal cells by self-MHC.
the surface of bone marrow-derived thymic stromal cells (16, 17) . A central paradox is how similar interactions that take our findings are of general physiological relevance. Highaffinity binding of B6.2.16 TCR by the HY/H-2D b resulted in place between TCR and self-peptide/MHC complexes trigger different cell fates during the two types of thymic selection, negative selection and low-affinity binding by non-agonist, self-peptide/H-2D b molecules resulted in positive selection. and so give rise to T cells that recognize MHC-restricted antigen but are largely tolerant to self.
Relatively small differences in self-peptide/MHC affinity for thymocyte TCR determined whether self-peptides could The nature of the MHC ligand that triggers the selection of CD8 ϩ T cells has been studied in experiments using cultured induce positive selection and so would account for the selfpeptide specificity of B6.2.16 CD8 cell positive selection. fetal thymi from class I MHC-deficient mice (18) (19) (20) (21) (22) . In transporter of antigen-1 (TAP1)-deficient mice the surface expression of class I MHC is impaired, which results in a Methods block in the positive selection of CD8 ϩ cells (23). The surface expression of MHC class I molecules can be partially restored Peptides in cultured fetal thymi from TAP1 -mice by the addition of
The following peptides were synthesized (The University of peptide which stabilizes 'empty' class I MHC molecules on Chicago, Cancer Research Oligopeptide Synthesis Facility): thymic stromal cells (18) . It was observed that the positive amino acids 100-108 of mouse brain protein E46 [NSIRNLDTI] selection of CD8 ϩ thymocytes was specific for the peptide (BP), amino acids 634-642 of mouse ribonucleotide reductase presented by class I MHC on thymic stromal cells, which led M1 [FQIVNPHLL] (RR), amino acids 76-84 of mouse histone to the view that the positive selection of CD8 ϩ cells depends H2A. 1 [LAIRNDEEL] (HH) (30) and amino acids 738-746 of on the specific recognition of thymic self-peptides (18, 24) .
the Smcy protein [KCSRNRQYL] (HY) (29) . Reverse-phase Further studies indicated that the ability of non-thymic, anti-HPLC showed that the purity of each of the peptides was gen-variant peptides to induce the positive selection of CD8 ϩ Ͼ95%. The correct sequence of the peptides was confirmed T cells, when added to cultured fetal thymi from TAP1 -mice, by a combination of amino acids analysis and ion-spraywas influenced by the density of peptide on stromal cells and mass spectrometry. the innate ability of peptides to stimulate the TCR (19). This led to a model of T cell selection in which the avidity of Protein expression the TCR:peptide/MHC interaction is a critical parameter in Inclusion bodies of human β 2 -microglobulin (hβ 2 m) or the determining thymocyte cell fate (19, 25, 26) . Avidity is defined mouse H-2D b -heavy chain with a biotinylation tag (biotHas the overall strength of interaction and is the product of the 2D b -heavy chain) were recovered from Escherichia coli using affinities of interaction between TCR (including CD4 or CD8 a modified version of a previously described procedure (31). co-receptors) and peptide/MHC and their respective cell
In brief, BL21 (DE3) pLysS cells were grown at 37°C in Luriadensities. High avidity interactions give negative selection Bertani medium containing 50 µg/ml carbenicillin (hβ 2 m) or and low-avidity interactions give positive selection. This model 50 µg/ml kanamycin (biotH-2D b -heavy chain). Isopropyl predicts that the affinity of self-peptide/class I MHC for β-D-thiogalactopyranoside (IPTG; Sigma, St Louis, MO) was thymocyte TCR determines whether a cell undergoes positive added to a final concentration of 0.5 mM when the culture or negative selection. Furthermore, the model implies that reached an OD 600 of~0.6. After 4 h, the bacteria were self-peptide specificity of CD8 ϩ cells selection would be a harvested and lysed by repeated sonication in lysis buffer result of differences in affinity between TCR and self-peptide/ [20 mM Tris-HCl (pH 8.0), 23% sucrose, 1 mM EDTA] class I MHC molecules. However, to date there is no direct containing 0.5% Triton X-100 and 40 µg/ml DNase I (Boehrevidence that the affinity between TCR and self-peptide/MHC inger Mannheim, Mannheim, Germany). After two washes with molecules, which are actually expressed in the thymus, lysis buffer, the purified inclusion bodies were dissolved in determines the developmental fate of thymocytes.
20 mM Tris-HCl (pH 8.0), 4 M urea. To examine the role of thymic self-peptides in positive and negative selection of CD8 ϩ cells, we measured the binding Refolding and purification tetrameric peptide/H-2D b comof thymic self-peptide/H-2D b molecules to a TCR expressed plexes by CD8 ϩ cells. The B6.2.16 TCR (27) expressed on CD8 ϩ cells recognizes a male-specific, self-peptide negative (HY, Peptides were dissolved in 20 mM Tris (pH 8.0), 4 M urea and then mixed with biotH-2D b -heavy chain and hβ 2 m at a human Y) that is expressed in the thymus (28, 29) . We demonstrate the high-affinity binding of multimeric HY/H-2D b molar ratio of 3:3:1. The mixtures were dialyzed against 20 mM Tris-HCl (pH 8.0), 150 mM NaCl at 4°C in Spectra Por CE tetramers to B6.2.16 on CD8 ϩ cells (referred to as B6.2.16 CD8 cells hereafter). The B6.2.16 TCR bound non-antigenic, dialysis tubing (Spectra, mol. wt cut of 500 kDa; Spectrum, Houston, TX) for 48 h. The soluble fraction was incubated for thymic self-peptide/H-2D b tetramers over a range of affinity that was significantly lower than that of the TCR for the 1 h at 37°C and centrifuged at 15,000 g to remove precipitates. Correctly folded peptide/H-2D b complexes were purified antigenic HY/H-2D b tetramer. We examined the consequences of TCR binding to self-peptide/H-2D b on the positive and using an anti-H-2D b mAb affinity column (B22-249R1) that was coupled at a density of 10 mg/ml to Protein A resin negative selection of B6.2.16 CD8 cells in fetal thymi from TAP1-deficient mice. We found that the relative affinity of self-(Pharmacia, Uppsala, Sweden) with dimethylsuberimidate (Sigma) using standard procedures (32) . Upon elution with peptide/H-2D b for the B6.2.16 TCR determined the ability of the self-peptides to induce the positive or negative selection 100 mM triethylamine (pH 11.5) and neutralization with 1 M sodium phosphate buffer (pH 6.8), the trimeric complexes of B6.2.16 CD8 thymocytes. The self-peptides in our experiments are expressed at high levels in the thymus; therefore, were dialyzed into PBS and stored at 4°C or directly used for experiments. All purified complexes were subjected to For biotinylation, the peptide/hβ 2 m/biotH-2D b -heavy chain tetramers or the SA-PE control at the same concentration. The samples were directly analyzed by FACS, without washcomplexes were dialyzed overnight into 20 mM Tris-HCl (pH 8.0), 50 mM NaCl. Typically, 1-2 mg of protein at a ing, and the mean staining intensity of MHC tetramer-PE staining on CD8 ϩ splenocytes determined. The mean specific concentration of 1-2 mg/ml was incubated overnight with 3 µg of the enzyme BirA (Avidity, Denver, CO) in biotinylation fluorescence intensity (log 10 ) (mean MHC tetramer-PE fluorescence -mean fluorescence of SA-PE control) was plotted buffer [20 mM Tris-HCl (pH 8.0), 50 mM NaCl, 50 mM Bicine (pH 8.3), 10 mM ATP, 10 mM Mg acetate, 40 µM biotin, 1 mM against the concentration of MHC-tetramers. pefabloc (Boehringer Mannheim), 1 µg/ml leupeptin, 1 µg/ml Agonist assays pepstatin, 2 µg/ml aprotinin (Sigma)]. The uncoupled biotin was removed by dialysis against PBS and the efficiency of Male-specific B6.2.16 CTL were generated as described previously (29) (34) . Staining of thymocytes was performed as described previously (26) . Live cells were identified Purified H-2D b complexes at a concentration of 0.3 mg/ml in PBS/1% BSA were incubated at 37°C. Aliquots were taken at on the basis of forward and sideward light scattering properties. The log 10 fluorescence resulting from mAb staining was tϭ0 and at various time points during the incubation (up to 360 h). We determined the amount of peptide/H-2D b that determined on gated live cells using predetermined standard calibration of the flow cytometer. Data were analyzed using reacted with the B22-249R1 anti-H-2D b mAb, which is conformation dependent, and so distinguishes between correctly Cell Quest v1.2 software (Becton Dickinson, Mountain View, CA).
and incorrectly folded H-2D b molecules (5). The different samples were subjected to a 2 h immunoprecipitation with Intracellular IFN-γ expression by B6.2.16 CD8 cells was detected by staining with T3.70-FITC and anti-CD8-APC.
an excess of B22.249R1-coupled Protein A resin followed by six washes with PBS containing 1% NP-40. The samples were Upon fixation in 1% paraformaldehyde, the cells were permeabilized and stained in 0.3% saponin in PBS containing antitaken up in SDS-PAGE sample buffer with β-mercaptoethanol, boiled for 5 min and separated on a 15% SDS-PAGE gel. IFN-γ PE mAb (IgG2a) or the PE-labeled IgG2a isotype mAb control. After three washes in 0.03% saponin (PBS), IFN-γ Upon staining with Coomassie blue, the gel was directly analyzed by densitometry, and the intensity of the H-2D bexpression of B6.2.16 CD8 cells was analyzed by FACS.
heavy chain and the antibody light chain band was determined MHC tetramer staining using Image Quant software (Molecular Dynamics, Sunnyvale, CA). To control for equal loading, the densitometric values of Tetrameric PE-labeled peptide/MHC complexes were used for staining at the concentrations indicated. The staining was the H-2D b -heavy chain were corrected by the following factor: highest value of the antibody light chain band density of a performed for 2 h at 25°C in FACS buffer (2% FCS, 0.1% sodium azide in PBS) and the cells were washed once with sample on the gel/antibody light chain band of the analyzed sample. Assuming that the dissociation of H-2D b follows first-FACS buffer ഛ10 min before analysis. CD8 ϩ spleen cells from the following transgenic mice were analyzed by MHCorder kinetics, the percentage of correctly folded peptide/ H-2D b molecules was calculated: (the intensity of the H-2D (26) . Limiting dilutions of cells were plated at doses that ranged from 1000 to 30,000 (24 replicate wells per cell dose) Mice expressing the B6.2.16 TCR (C57BL/6/129Sv) were and co-cultured with irradiated female C57BL/6 spleen cells crossed with TAP1-deficient mice (23) TAP1 -/-, C57BL/6/ (1 ϫ 10 6 ) in cRPMI-containing rIL-2 (10 u/ml; Gibco/BRL). At 129Sv) to generate B6.2.16 ϩ/ϩ TAP1 -/-mice. B6.2.16 ϩ/ϩ the beginning of the culture and every second day, HY TAP1 -/-males were mated with TAP1 -/-or TAP1 ϩ/ϩ (C57BL/ peptide was added at a concentration of 10 -7 M. After 7 6) females to produce B6.2.16 ϩ/-TAP1 -/-and B6.2.16 ϩ/-days, the micro-cultures were assayed for cytolytic activity TAP1 ϩ/-fetal thymic, and FTOC performed as described to 51 Cr-labeled RMA target cells pulsed with HY peptide before (19). In brief, dissected fetal thymi (day 16 post-(10 -7 M). The cytolytically positive cultures were defined as coitum) were separated into individual lobes and cultured for those with 51 Cr release values exceeding the mean 10 days on sponges (Gelfoam; Upjohn, Kalamazoo, MI) spontaneous release by Ͼ3 SD. The CTL precursor frequenand polycarbonate filters (Millipore 0.8 µm; Fisher Scientific, cies were calculated using the Poisson distribution (26) . Pittsburgh, PA) in cRPMI-10 medium alone or in cRPMI-10 containing the indicated amount of peptide. The media with or without peptide were changed every 2 days.
Results
Binding of B6.2.16 CD8 cells to self-peptide/H-2D b tetramers Peptide/MHC class I complex stabilization analyses
The dual recognition of peptide and MHC by the TCR implies Stabilization of peptide/MHC complexes on TAP1 -thymic that TCRs may have the capacity to bind self-peptide/MHC stromal cells was analyzed as described previously (30 (Table 1 ). In addition, for 10 min at 37°C in cRPMI-10 alone or in media containing only the H-Y peptide, but neither of the self-peptides, induced MHC-tetramer (50 µg/ml), or the 145-2C11 mAb (anti-TCR the dulling of CD4 or CD8 when incubated in vitro with CD3ε-chain; 20 µg) (37) in a total volume of 0.5 ml. The cells thymocytes from B6.2.16 transgenic mice (data not shown). were lysed in lysis buffer [20 mM Tris-HCl (pH 7.6), 150 mM These data indicate that BP, RR or HH did not activate naive NaCl, 2 mM EDTA, 0.5% Triton X-100] to which 50 mM or effector B6.2.16 CD8 cells, and so we conclude that these sodium fluoride, 1 mM sodium vanadate, 30 mM sodium self-peptides are not agonists of the B6.2.16 TCR. pyrophosphate, 0.5 mM phenylmethylsulfonyl fluoride was To measure the binding of self-peptide/H-2D b molecules to added. The cleared supernatant was immunoprecipitated the B6.2.16 TCR, we generated tetrameric self-peptide/H-2D b with 1 µg of Protein A-bound mAb 145-2C11. After six washes molecules. Labeled tetrameric MHC molecules loaded with with lysis buffer, the samples were taken up in SDS-PAGE antigen peptide specifically stain a variety of T cells, and the sample buffer with β-mercaptoethanol, boiled for 5 min and affinity of monomeric peptide/MHC complexes correlates with separated on a 15% SDS-PAGE gel. The gel was immunothe staining intensity of tetrameric peptide/MHC complexes blotted and probed with anti-phosphotyrosine antibody 4G10 when analyzed by FACS (38) (39) (40) . We adapted this approach (Upstate Biotechnology, Lake Placid, NY) then by Protein Aand re-folded the HY peptide and non-agonist self-peptides HRP (Amersham, Piscataway, NJ). Phosphorylated proteins with recombinant H-2D b molecules, which carried a biowere detected using chemoluminescence detection (ECL; tinylation tag on the heavy chain C-terminus. To avoid possible Amersham). To control for equal loading the blot was stripped cross-reactivity of tetramers with non-transgenic TCR on and reprobed using rabbit anti-TCR ζ chain serum (generous B6.2.16 CD8 cells, spleen cells from B6.2.16 RAG1 -mice, gift from P. Allen, Washington University, St Louis, MO) followed which have impaired endogenous TCR gene rearrangement and so only express the B6.2.16 TCR, were stained with MHC by anti-rabbit Fc-HRP (ICN, Costa Mesa, CA). were stained for 2 h at 25°C with MHC tetramer-PE, and CD4-FITC, CD8-APC mAb then analyzed by FACS for log 10 fluorescence above the SA-PE control (shaded histogram). The ratio of mean log 10 fluorescence intensity resulting from MHC-tetramer staining compared to SA-PE control is indicated in the top right-hand corner. class I MHC restricted TCR. We found that CD8 ϩ cells from mAb (anti-clonotypic TCR; 100 µg/ml) was performed on CD8 ϩ cells. The specific staining was calculated from the ratio log 10 fluorescence mice expressing the D7 TCR, which is specific for the LemA from staining with MHC tetramers compared to SA-PE control and is peptide (fMIGWII), presented by the non-classical class I
shown in the upper right corner. These data are representative of more molecule H-2M3 wt (35) , expressed the same level of CD8 and than four independent experiments, each using different batches of CD3 as B6.2.16 CD8 cells ( Fig. 2A) . We then determined the MHC tetramers prepared independently.
extent of peptide/H-2D b tetramer staining on the surface of D7 CD8 cells. To avoid possible cross-reaction of nontransgenic TCR on D7 CD8 cells with self-peptide/H-2D b tetramers, spleen cells were purified from D7 transgenic mice tetramers (10 µg/ml) (41). As expected, we observed strong staining of CD8 ϩ spleen cells from B6.2.16 RAG1 -mice with that lack the expression of endogenous TCR α chain, thus ensuring that the CD8 cells express only the D7 TCR (42). tetrameric HY/H-2D b SA-PE (143-fold above background) (Fig. 1) . The staining was blocked by the clonotypic antiWe observed no specific staining over background of D7 CD8 cells with HY/H-2D b or self-peptide/H-2D b tetramers B6.2.16 TCR mAb T3.70 (33), but not an isotype control mAb (data not shown), indicating that it was specific for the B6.2.16 (Fig. 2B) . Since the level of TCR was the same on CD8 cells expressing either the D7 (H-2M3 wt restricted) or B6.2.16 TCR (Fig. 1) .
But specific staining was not only observed with the antigen (H-2D b restricted) TCR, we conclude that binding of selfpeptide/H-2D b tetramers to B6.2.16 CD8 cells is specific for MHC tetramer; in addition the non-agonist, self-peptide MHC tetramers exhibited TCR-specific staining of CD8 ϩ splenothe B6.2.16 TCR. Furthermore, the expression of CD8 on D7 CD8 cells was not sufficient to mediate self-peptide/H-2D b cytes from B6.2.16 RAG1 -mice (Fig. 1) We next examined the contribution of TCR and CD8 to the α1/α2 domains of H-2D b . Spleen cells from B6.2.16 RAG1 -, P14 RAG1 -or D7 TCRα -mice (2 ϫ 10 5 ) were stained with H-2D b tetramers (20 µg/ml) and analyzed by FACS as described in Fig. 1 . The peptide and MHC specificity of each transgenic TCR are indicated in parentheses. The specific staining was calculated from the ratio of mean log 10 fluorescence intensity resulting from MHC tetramer staining compared to SA-PE. All three self-peptide/H-2D b tetramers specifically stained P14 CD8 cells but did not stain CD8 cells expressing the H-2M3 wtrestricted D7 TCR ( (Fig. 1) . However, the weak staining of the self-peptide/H-2D b tetramers could We wanted to determine whether the affinity between the B6.2.16 TCR and self-peptide/H-2D b molecules, expressed equally be due to a relatively high-affinity interaction that has a high off-rate. We therefore titrated the concentration of selfon thymic epithelial cells, determines the positive selection of B6. (Fig. 3) . HH/H-2D b tetramers had the lowest affinity for the B6.2.16 TCR. At 10 µg/ml the staining intensity of FTOC, indicating a block in positive selection due to low class I MHC molecule expression (18,23) ( Fig. 4A and B) . Limiting HY/H-2D b was 50 (arbitrary units), whereas that for RR/H-2D b (250 arbitrary units) and BP/H-2D b was higher (150 arbitrary dilution analysis revealed a correspondingly low frequency of anti-HY CTL precursors from female B6.2.16 TAP1 -FTOC units). However, as we found previously (Fig. 1) , the specific staining with the HY/H-2D b tetramer was by far the greatest.
( Table 3 ). The addition of all three self-peptides at 300 µM to B6.2.16 At 10 µg/ml the specific staining with HY/H-2D b tetramers was 10 times higher than that of the RR/H-2D b tetramer, 30 TAP1 -FTOC led to the rescue of H-2D b expression on TAP1 -thymic stromal cells (Table 4 ). The addition of the selftimes higher than BP/H-2D b tetramer and 60 times higher than HY/H-2D b (Fig. 3) .
peptides BP and HH (40-64 and 40-57% of the TAP1 ϩ level respectively) led to a greater rescue in surface H-2D b To control for any differences in the relative stability of selfpeptide/H-2D b molecules we determined the half-lives of each expression than RR (17-27% of the TAP1 ϩ level) when added at 300 µM. However, only BP or RR, but not HH, at 37°C. The HY/H-2D b complex was relatively unstable with Using limited dilution analysis, the frequency of anti-HY CTL precursors was determined from female B6.2.16 TAP1 ϩ and TAP1 -thymi incubated with and without BP. The range of CTL precursors frequencies obtained over three independent FTOC experiments is shown. The percentage of CTL precursors is the frequency multiplied by 100. Table 4 . Relative abilities of self-peptides to stabilize H-2D b on TAP1 -thymic stromal cells
The surface expression of H-2D b , on gated I-A bϩ thymic stromal cells, from TAP1 ϩ and TAP1 -FTOC, incubated with or without peptide for 3 days, was quantitated by determining the log 10 mean fluorescence intensity resulting from staining of cells with anti-H-2D b mAb (B22-249R1). The degree of rescue of H-2D b by peptide on thymic stromal cells is expressed as a percentage of the TAP1 ϩ value, less the background level from TAP1 -FTOC incubated without (Fig. 4B) . Therefore, the expression of anti-HY CTL-precursors compared to B6.2.16 TAP1 -FTOC cultured alone (Table 3) , thus demonstrating the positive selection of functionally viable B6.2.16 CD8 cells by exogenously provided self-peptides. led to an accumulation of B6.2.16 CD8 cells when added to B6.2.16 TAP1 -FTOC (Fig. 4A and B) . The addition of BP The inability of HH to induce B6.2.16 CD8 cell positive selection was not due to low density on TAP1 -thymic stromal tyrosine kinases leading to cell activation (43) . We examined the signals transduced by the TCR complex of CD8 thymocytes from B6.2.16 RAG1 -mice after self-peptide/H-2D b tetramer binding. First, the TCR complex was immunoprecipitated from detergent extracts of ex vivo thymocytes from or anti-CD3 mAb resulted in the induction of the hyperphosphorylated p23 form of TCR ζ and the phosphorylation B6.2.16 RAG1 -mice with anti-CD3ε mAb (145-2C11) and immunoblotted with anti-phosphotyrosine mAb (4G10). This of other CD3 complex related proteins (Fig. 6 ). This pattern is consistent with that observed after stimulation of polyclonal showed that only the TCR ζ chain is phosphorylated (p21 form) in B6.2.16 thymocytes in vivo, as demonstrated previously in thymocytes with anti-CD3 mAb (44). However, tetramers of BP or RR/H-2D b , which bind the B6.2.16 TCR with low affinity, non-transgenic C57BL/6 thymocytes (44) (Fig. 6) .
We then examined whether the high-affinity binding HY/Hdid not induce the hyper-phosphorylation of TCR complex ζ or any other TCR related phosphoprotein (Fig. 6) /ml; Fig. 3 ). Binding with HY/H-2D b tetramers of antigen or self-peptide entrenched in the binding pocket (3,4,46). Therefore, one could postulate that contacts between TCR and α1/α2 domains provide the necessary low-affinity binding that drives positive selection. The contribution of TCR CDR3 binding to self-peptide would be quite small and so a variety of different self-peptides can be recognized by the same TCR (46) .
We found that a minimal affinity of self-peptide binding to the B6.2.16 TCR is required to trigger B6.2.16 CD8 cell positive selection. The BP and RR self-peptides had a higher (Table 1 and Fig. 4D) . Although RR had a higher affinity (-) . In addition, SA-PE (Str) at a concentration equivalent to the SA-PE in the MHC tetramers (12.5 µg/ml) was added. The TCR/CD3 than BP for the B6.2.16 TCR, we found that the degree of complex was precipitated from lysates with the mAb 145-2C11, B6.2.16 CD8 cell positive selection triggered by each selfresolved by SDS-PAGE and immunoblotted with anti-phosphotyrosine peptide was about the same (Fig. 4D) . This is probably due antibody 4G10 (α-pTyr) then rabbit anti-TCRζ chain serum (α-TCRζ).
to the fact that after the addition of self-peptides to B6.2.16
The positions of the heavy chain of the precipitating antibody (IgH), the p21 (21 kDa) and p23 (23 kDa) form of the precipitated TCR ζ TAP1 -FTOC the expression of RR on TAP1 -thymic stromal chain (ζ-chain) are indicated. This experiment is representative of cells was lower than that of BP (Table 4) and is consistent two independent experiments. with previous observations that peptide/MHC density, on thymic stromal cells, as well as affinity for thymocyte TCR determines the extent of positive selection (25) .
The binding of the P14 TCR to H-2D b tetramers was more Discussion specific for the RR self-peptide than the binding of the B6.2.16 TCR ( Table 2 ). This explains our earlier finding that, unlike Positive selection educates thymocytes to recognize peptide presented by self-MHC and so predicts that mature T cells B6.2.16 CD8 cell positive selection, the positive selection of P14 CD8 cells was only induced by RR in TAP1 -FTOC may possess inherent reactivity to self-peptide/MHC. In this study, we examined the consequences of the reactivity of a (30) . Taken together, these studies imply that the degree of specificity of TCR binding to thymic self-peptide/class I MHC TCR for self-peptide/MHC on thymic selection. We found that the relative affinity of TCR binding to self-peptide/class I MHC determines the self-peptide specificity of CD8 cell positive selection. molecules determines whether thymocytes undergo positive or negative selection.
The self-peptides used in our studies are among the most abundant peptides eluted from H-2D b molecules expressed Experiments with multivalent self-peptide/H-2D b tetramers revealed that the B6.2.16 TCR binds thymic self-peptide/Hon thymic epithelium and together account for 12-23% of total H-2D b -presented self-peptide (30) . Therefore, the differ-2D b (Fig. 1) . Antibody blocking experiments with the clonotypic T3.70 mAb (specific for the B6.2.16 TCR α chain) ences in TCR:self-peptide/H-2D b affinity that control CD8 ϩ cell positive selection may be of general physiological relevance. showed that the antigen-binding domain of the TCR interacts with the H-2D b . The potential reactivity self-peptide/H-2D b
Previous work using antigen-variant peptides, which are not normally expressed in the thymus, also indicated that the tetramers for CD8 was not sufficient to account for the staining of B6.2.16 CD8 cells (Fig. 2) . Thus, the binding of self-peptide/ affinity between peptide/MHC molecules and TCR determines the outcome of thymocyte selection (21,47). It was reported H-2D b tetramers was specific for the B6. The level of H-2D b stabilization by self-peptides on thymic stromal cells in B6.2.16 TAP1 -FTOC was relatively high; or that self-peptide indirectly influences TCR binding to the α1/α2 domains of H-2D b (45) .
indeed BP and HH led to the rescue of~50% of the normal TAP1 ϩ level of H-2D b (Table 4) . Despite this, the number of We found that the B6.2.16 TCR could bind three different non-agonist, self-peptide/H-2D b tetramers despite the fact B6.2.16 CD8 ϩ cells generated was never more than twice (17% of B6.2.16 TAP1 -FTOC level) the level of unsupplethat the potential TCR contact residues (P1-P4; P6-P8) of each self-peptide are dissimilar (Figs 1 and 3) . Therefore, we mented B6.2.16 TAP1 -lobes (8% of B6.2.16 TAP1 ϩ FTOC level) (Fig. 4D) . It is likely that positive selection in normal conclude that the binding of the B6.2.16 TCR to self-peptide/ H-2D b is quite degenerative (cross-reactive). The plasticity of thymi requires TCR binding to certain self-peptide/H-2D b molecules that have a higher affinity for the TCR than those TCR:self-peptide/H-2D b binding may be explained by the Xray crystal structures of TCR:MHC class I complexes. These studied in this paper. However, studies with antigen-variant peptides suggest that the density of 'high-affinity' self-pepstudies revealed a high proportion of contacts between TCR and MHC α1/α2 domain residues, which are independent tides, on normal thymic stromal cells, will probably be lower The finding that self-peptide/MHC affinity for TCR deter-
